Screener
Gilead Sciences GILD Sales Rebates and Discounts
Sales Rebates and Discounts at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept gild:AccountsReceivableChargebacksCurrent.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
| (in millions) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable(1) | $5,902 | $5,895 |
| Less: allowances for chargebacks | (671) | (843) |
| Less: allowances for cash discounts and other | (125) | (97) |
| Less: allowances for credit losses | (51) | (41) |
| Accounts receivable, net | $5,055 | $4,913 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Gilead Sciences's sales rebates and discounts?
- Gilead Sciences (GILD) reported sales rebates and discounts of $671M in Q2 2026.
- How has Gilead Sciences's sales rebates and discounts changed year-over-year?
- Gilead Sciences's sales rebates and discounts decreased by 3.6% year-over-year, from $696M to $671M.
- What is the long-term trend for Gilead Sciences's sales rebates and discounts?
- Over 5 years (2020 to 2025), Gilead Sciences's sales rebates and discounts has grown at a 8.8% compound annual growth rate (CAGR), from $552M to $843M.
- What does sales rebates and discounts mean?
- Accrued liabilities for estimated rebates, discounts, and chargebacks owed to customers.
Ask your AI about Gilead Sciences's sales rebates and discounts.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude